Pfizer Q1 Results: Net Profit Jumps 7%, Revenue Increases 8% To Rs 653 Crore

Pfizer Q1 Results: Pharmaceutical major Pfizer has reported a steady financial performance for the first quarter in FY27, posting a 6.6% year-on-year (YoY) increase in net profit. The company's bottom line grew to Rs 205 crore, up from Rs 192 crore in the corresponding quarter of the previous fiscal year, driven by healthy operational metrics and consistent top-line growth. Revenue for the quarter climbed 8.3% YoY to Rs 653 crore, compared to Rs 603 crore reported in the same period last year. The growth highlights the company's resilient sales performance across its core pharmaceutical portfolios. 

Pfizer Q1 Results: Highlights (Cons, YoY)

Net Profit up 6.6% to Rs 205 crore Vs Rs 192 crore YoY
Revenue up 8.3% to Rs 653 crore Vs Rs 603 crore YoY
EBITDA up 17.9% to Rs 248 crore Vs Rs 210 crore YoY
EBITDA Margin At 37.9% Vs 34.8% YoY
Other Income At Rs 44.8 crore Vs Rs 67.2 crore YoY

ALSO READ: Coal India Share Price Drops 3% As Brokerages Trim Target On Q1 Earnings Miss: Buy, Sell, Or Hold?

Operational Efficiency Drives Margin Expansion

The standout metric for the quarter was operational efficiency. Pfizer saw a robust 17.9% surge in its earnings before interest, taxes, depreciation, and amortization (EBITDA), which came in at Rs 248 crore. The strong operational execution resulted in a significant expansion in profitability. EBITDA margin expanded by 310 basis points to reach 37.9%, up from 34.8% in the year-ago period.

However, the overall net profit growth was slightly moderated by a sharp drop in other income, which fell to Rs 44.8 crore during the quarter, compared to Rs 67.2 crore in the same period last year. Despite this drag, the core business strength and improved margin profile kept the quarterly results in positive territory for the global pharma giant.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.